JP2009533341A5 - - Google Patents

Download PDF

Info

Publication number
JP2009533341A5
JP2009533341A5 JP2009504226A JP2009504226A JP2009533341A5 JP 2009533341 A5 JP2009533341 A5 JP 2009533341A5 JP 2009504226 A JP2009504226 A JP 2009504226A JP 2009504226 A JP2009504226 A JP 2009504226A JP 2009533341 A5 JP2009533341 A5 JP 2009533341A5
Authority
JP
Japan
Prior art keywords
less
oil
composition
active agent
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009504226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009533341A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/008054 external-priority patent/WO2007123790A1/en
Publication of JP2009533341A publication Critical patent/JP2009533341A/ja
Publication of JP2009533341A5 publication Critical patent/JP2009533341A5/ja
Pending legal-status Critical Current

Links

JP2009504226A 2006-04-07 2007-04-03 抗細菌、抗真菌、抗酵母、および/または抗ウイルス特性を有するナノ構造組成物 Pending JP2009533341A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78991706P 2006-04-07 2006-04-07
PCT/US2007/008054 WO2007123790A1 (en) 2006-04-07 2007-04-03 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties

Publications (2)

Publication Number Publication Date
JP2009533341A JP2009533341A (ja) 2009-09-17
JP2009533341A5 true JP2009533341A5 (cg-RX-API-DMAC10.html) 2010-04-30

Family

ID=38436994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504226A Pending JP2009533341A (ja) 2006-04-07 2007-04-03 抗細菌、抗真菌、抗酵母、および/または抗ウイルス特性を有するナノ構造組成物

Country Status (6)

Country Link
EP (1) EP2010149A1 (cg-RX-API-DMAC10.html)
JP (1) JP2009533341A (cg-RX-API-DMAC10.html)
CN (1) CN101466355A (cg-RX-API-DMAC10.html)
AU (1) AU2007240983A1 (cg-RX-API-DMAC10.html)
CA (1) CA2648360A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007123790A1 (cg-RX-API-DMAC10.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504805A (ja) 2005-08-09 2009-02-05 ナノバイオ コーポレーション 抗炎症活性を有するナノエマルジョン組成物
WO2008039864A1 (en) * 2006-09-26 2008-04-03 Novavax, Inc. Emulsion formulations for transdermal delivery of poorly water soluble active agents
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
WO2008157092A1 (en) 2007-06-20 2008-12-24 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
MX2012000105A (es) * 2009-06-30 2012-03-14 Univ Columbia Composiciones antimicrobianas/conservadoras que comprenden extractos botanicos.
AU2012332495B2 (en) 2011-11-03 2017-06-08 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013086094A1 (en) 2011-12-06 2013-06-13 The Trustees Of Columbia University In The City Of New York Broad spectrum natural preservative composition
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
FR2997304B1 (fr) * 2012-10-26 2017-07-07 Isp Investments Inc Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP6248331B2 (ja) * 2013-01-25 2017-12-20 ケミラ ユルキネン オサケイティエKemira Oyj 殺生物剤組成物及び水の処理方法
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
CA2990941C (en) * 2015-07-01 2024-02-20 Nissim Garti Delivery systems for propofol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105241793B (zh) * 2015-09-07 2016-10-26 国家纳米科学中心 一种载药胶束形态粒径的测定方法
CN111759823B (zh) * 2015-09-17 2022-12-30 阿赖耶识(上海)生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN113728865B (zh) * 2021-09-24 2022-12-13 广西壮族自治区亚热带作物研究所(广西亚热带农产品加工研究所) 一种澳洲坚果促花保果的综合管理方法
BE1030538B1 (nl) * 2022-05-18 2023-12-19 Bogaert Gina Van Liposomaal preparaat met ingekapselde hormonen, werkwijze voor de productie en gebruik ervan
WO2025054263A2 (en) * 2023-09-06 2025-03-13 The Board Of Regents Of The University Of Texas System Compositions and methods of ent-testosterone for treatment of bacterial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
EP1633322A2 (en) * 2003-06-04 2006-03-15 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof

Similar Documents

Publication Publication Date Title
US9976108B2 (en) Ethanol-free microemulsion perfuming compositions
KR101087602B1 (ko) 피부 외용제 조성물
JP2013508296A5 (cg-RX-API-DMAC10.html)
JP2020514342A5 (cg-RX-API-DMAC10.html)
US20110212169A1 (en) METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended)
AU2014359195A1 (en) Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
TW201714605A (zh) 具有可逆的連續及分散相之奈米乳液
WO2008032327A3 (en) Organic nanoparticles obtained from microemulsions by solvent evaporation
TW201315484A (zh) 油中水型乳化防曬化妝料
JP2013507337A5 (cg-RX-API-DMAC10.html)
RU2008138056A (ru) Композиции, пригодные для отбеливания зубов
CN102026663A (zh) 油质体中活性剂的控制释放
JP2009533341A (ja) 抗細菌、抗真菌、抗酵母、および/または抗ウイルス特性を有するナノ構造組成物
CA2494796A1 (en) Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
US20180036243A1 (en) Nanoparticulate composition
FR3070865A1 (fr) Solution huileuse d'alcool benzylique et utilisation dans la prevention et le traitement des parasitoses
JP5950528B2 (ja) 皮膜形成性外用製剤
JP2009143878A5 (cg-RX-API-DMAC10.html)
JP3786607B2 (ja) 湛水下水田の直接散布用水性懸濁製剤
ES2888125T3 (es) Composiciones y métodos de limpieza
ES2337152T3 (es) Procedimiento de tratamiento no terapeutico para animales de compañia.
JP2020520932A (ja) 二相化粧品組成物
Ang Azlan et al. The role of natural plants with incorporation of tocopherols, ubiquinone and tocotrienols in nanoemulsion formulation: a mini review
FR3007284B1 (fr) Association synergique de trois composes lipophiles et utilisations
JP2009505976A5 (cg-RX-API-DMAC10.html)